Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1393 | Pituitary Clinical | ICEECE2012

Carboplatin is a novel cause of the syndrome of inappropriate antidiuresis

O'Brien M. , Hannon M. , Lavan A. , Thompson C.

The syndrome of inappropriate antidiuresis (SIAD) is characterised by plasma hyponatraemia and plasma hypoosmolality with a high urinary sodium in a clinically euvolaemic patient. We describe only the second reported case of SIAD due to carboplatin administration, with consequent acute severe hyponatraemia.A 61-year-old lady with no background history of note received neoadjuvant carboplatin and paclitaxel for stage III ovarian carcinoma. Five days after...

ea0015p264 | Pituitary | SFEBES2008

Mechanism of C-type natriuretic peptide (CNP) stimulated phosphorylation of ERK-MAPK in pituitary GH3 somatotrophs

Jonas Kim , Thompson Iain , Fowkes Rob

CNP, the third peptide of the mammalian natriuretic peptide family, exerts its biological effects through activation of the guanylyl cyclase B (GC-B) receptor and resulting cGMP accumulation. Our previous studies reported that CNP stimulates phosphorylation of MAPK family proteins in GH3 somatotrophs. This present study aimed to further characterise the mechanism of CNP-stimulated ERK phosphorylation and resulting biological consequences in GH3 cells. Western blot analyses sho...

ea0015p269 | Pituitary | SFEBES2008

Homologous and heterologous desensitization of guanylyl cyclase-B (GC-B) receptor in GH3 somatotrophs: mechanisms to control the effects of C-type natriuretic peptide (CNP)

Thompson Iain , Wheeler-Jones Caroline , Fowkes Rob

Natriuretic peptides, ANP, BNP and CNP, exert the majority of their effects via particulate guanylyl cyclase receptors (GC-A or GC-B), resulting in increased cellular cGMP levels. Several studies have examined the pharmacological properties of GC-B receptors in many systems, and desensitization (tachyphylaxis, loss of response) has been reported to occur. Targeted deletion (in mice) or genetic mutations (in humans) of the GC-B receptor have been implicated in a dwarfism phenot...

ea0015p271 | Pituitary | SFEBES2008

Molecular and functional components of a gonadotroph natriuretic peptide system in α T3-1 and LβT2 cells

Thompson Iain , Wheeler-Jones Caroline , Fowkes Rob

Gonadotrophs have previously been shown to be the predominant source of C-type natriuretic peptide (CNP) in the anterior pituitary, and CNP causes enhanced cGMP accumulation in αT3-1 gonadotrophs. However, the biological role of CNP in gonadotrophs remains elusive. In the current study, we examined the molecular and functional characteristics of the gonadotroph natriuretic peptide system. Using two well-characterised gonadotroph cell lines of different developmental origi...

ea0013p249 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Sleep disorders in craniopharyngioma patients – a preliminary report

Crowley Rachel , Costello Richard , Thompson Christopher

Objective: Our aim was to identify and treat sleep disorders in asymptomatic patients with craniopharyngioma and to identify co-existing respiratory disease.Methods: 5 patients (1 male) with a diagnosis of craniopharyngioma, were identified from the local pituitary database and admitted for polysomnography (Alice 4, Respironics), as part of a study of hypothalamic disease in craniopharyngioma. Sleep disturbance was defined as an apnoea index (AHI) of &#6...

ea0012oc20 | Pituitary, ovary and steroids | SFE2006

Novel activation of MAPK family proteins in pituitary GH3 somatotrophs and alphaT3-1 gonadotrophs by C-type natriuretic peptide (CNP)

Jonas KC , Thompson IA , Chand AN , Fowkes RC

In target tissues, CNP acts via the cell surface guanylyl cyclase B (GC-B) receptor to stimulate cGMP accumulation. Transgenic mice studies deleting either CNP or the GC-B receptor suggest a role for CNP in regulating bone formation and pituitary growth hormone secretion. Our previous studies have implicated a role for CNP in inhibiting calcium transients in alphaT3-1 pituitary gonadotroph cells; however the biological consequence of cGMP accumulation remains unclear. Therefor...

ea0007p284 | Clinical case reports | BES2004

Late recovery of pituitary function following traumatic brain injury

Ryan J , Agha A , Sherlock M , Thompson C

Anterior pituitary dysfunction is a well-recognized complication of traumatic brain injury (TBI) but recovery is an exceptional event, with only three previously published case reports.We report a case of a 25 year old man who suffered severe TBI in a road traffic accident in 1997. His neurological recovery was slow and incomplete with significant cognitive deficit and recurrent seizures. He developed polyphagia and his weight increased by 20 Kilograms i...

ea0005p182 | Neuroendocrinology and Behaviour | BES2003

Hypopituitarism following cranial irradiation for non-pituitary brain tumours

Agha A , O'Connor S , Rogers B , Thompson C

There is little information on the effects on pituitary function of cranial irradiation for non-pituitary tumours. We have studied anterior and posterior pituitary function in 17 patients (6 males), with a median age 19 years (range 5-48) at the time of radiotherapy. 16 patients had primary brain tumours and one had acute lymphocytic leukaemia. The patients were selected by the radiotherapists for investigation . Pituitary functions were assessed at a median of 60 months (rang...

ea0077oc6.3 | Thyroid | SFEBES2021

Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM Stage I Papillary Thyroid Carcinoma

Hay Ian , Kaggal Suneetha , Mullan Brian , Thompson Geoffrey

Background: To determine whether radioiodine remnant ablation (RRA) reduces cause-specific mortality (CSM) or tumor recurrence (TR) rates after bilateral thyroidectomy (BT) in low-risk adult papillary thyroid carcinoma (APTC) patients treated with curative intent, we compared outcome in 1836 stage I patients having BT alone with 832 having BT+RRA.Methods: THEN cohort (1966-1990) comprised 809 patients; 36% having RRA within 6 postoperative months. NOW co...

ea0084op-09-42 | Oral Session 9: Thyroid Cancer Clinical | ETA2022

Childhood papillary thyroid carcinoma: long-term postoperative outcome and prediction of recurrent disease in 189 patients consecutively treated at the mayo clinic during 1936 through 2020

Hay Ian , Kaggal Suneetha , Rivera Michael , Pittock Siobhan , Thompson Geoffrey

Objectives: Childhood papillary thyroid cancer (CPTC) often presents with advanced disease but rarely results in cause-specific mortality (CSM). Controversy remains regarding optimal management and association with non-thyroid second primary malignancies (NSPM). We analyzed outcome in 189 CPTC patients and assessed the influence of radioiodine remnant ablation (RRA) and the utility of the American Thyroid Association risk-groups (ATA-R) in predicting tumor recurrence (TR)....